Clinical Trial

Grape Seed Powder and Vitamin C Supplementation for Liver Disease (Acquired Hepatic Jaundice)

Study acronym: AHJ
Completed
View on ClinicalTrials.gov →
Summary
Jaundice is a frequent medical problem that affects people of all ages. It is important to note that jaundice is not an actual sickness as such itself but rather a symptom of liver illness brought on by an increase in the quantity of bilirubin circulating in the blood owing to improper metabolism and excretion in the urine. The aim of this investigation is to investigate the impact of grape (Vitis Vinifera) seed powder along with vitamin C supplementation on serum bilirubin levels in patients with acquired hepatic jaundice. In addition, it's the first research of its kind to investigate the aforementioned function of grape seed extract with vitamin C in healthy individuals specifically.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-04.
Trial Details
NCT Number NCT07575789
Lead Sponsor University of Lahore Hospital (ULH)
Conditions Jaundice
Enrollment 24 participants
Start Date 2023-03-03
Primary Completion 2023-03-17 (estimated)
Study Completion 2023-04-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-12